Zenotech Laboratories Limited (BOM:532039)

Zenotech Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	286.76	304.24	267.02	196.86	111.42	24.15
Short-Term Investments	-	-	-	0.02	-	-
Cash & Short-Term Investments	286.76	304.24	267.02	196.88	111.42	24.15
Cash Growth	-9.64%	13.94%	35.63%	76.69%	361.42%	-1.75%
Accounts Receivable	18.71	89.66	74.54	32.49	33.24	39.28
Other Receivables	-	11.41	11.22	15.33	6.76	1.58
Receivables	18.71	101.07	85.77	47.82	39.99	40.86
Inventory	15.54	0.73	0.91	8.6	0.24	1.35
Prepaid Expenses	-	1.81	2.04	1.39	2.98	3.84
Other Current Assets	38.95	2.54	2.19	6.94	8.01	3.56
Total Current Assets	359.96	410.39	357.94	261.63	162.65	73.75
Property, Plant & Equipment	681.86	658.93	644.41	675.38	703.64	711.88
Long-Term Deferred Tax Assets	1.61	-	39.4	65.26	93.58	122.75
Other Long-Term Assets	55.32	42.21	66.69	59.8	48.87	32.46
Total Assets	1,099	1,112	1,108	1,062	1,009	940.84

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	45.56	36.96	25.24	32.92	34.77	20.66
Accrued Expenses	48.53	75.65	81.36	97.15	126.19	129.98
Current Income Taxes Payable	-	-	12.15	-	-	-
Current Unearned Revenue	-	5.11	5.11	5.11	5.11	5.11
Other Current Liabilities	51.71	2.84	0.14	0.05	-	-
Total Current Liabilities	145.79	120.56	124	135.23	166.07	155.76
Long-Term Debt	-	-	-	-	-	60
Long-Term Unearned Revenue	-	0.19	0.94	9.7	9.73	3.21
Pension & Post-Retirement Benefits	-	12.15	7.09	6.16	5.26	4.52
Long-Term Deferred Tax Liabilities	-	8.31	-	-	-	-
Other Long-Term Liabilities	31.73	19.1	15.1	5.55	4.97	10.95
Total Liabilities	177.52	160.32	147.13	156.65	186.03	234.44

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	610.31	610.31	610.31	610.31	610.31	610.31
Additional Paid-In Capital	-	2,095	2,095	2,095	2,095	2,095
Retained Earnings	-	-1,755	-1,744	-1,800	-1,883	-1,999
Shareholders' Equity	921.24	951.21	961.31	905.42	822.7	706.4
Total Liabilities & Equity	1,099	1,112	1,108	1,062	1,009	940.84

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	-	-	-	-	-	60
Net Cash (Debt)	286.76	304.24	267.02	196.88	111.42	-35.85
Net Cash Growth	-9.64%	13.94%	35.63%	76.69%	-	-
Net Cash Per Share	4.36	4.99	4.38	3.23	1.83	-0.59
Filing Date Shares Outstanding	61.27	61.03	61.03	61.03	61.03	61.03
Total Common Shares Outstanding	61.27	61.03	61.03	61.03	61.03	61.03
Working Capital	214.17	289.83	233.94	126.4	-3.42	-82.01
Book Value Per Share	15.04	15.59	15.75	14.84	13.48	11.57
Tangible Book Value	921.24	951.21	961.31	905.42	822.7	706.4
Tangible Book Value Per Share	15.04	15.59	15.75	14.84	13.48	11.57
Land	-	10.83	10.83	10.83	10.83	10.83
Buildings	-	224.47	212.53	211.96	211.96	211.96
Machinery	-	1,013	939.58	917.68	844.97	828.49
Construction In Progress	-	36.03	35.73	19.56	49.79	2.79

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error